What does SafeHeal do?
SafeHeal is a clinical-stage medical device company focused on developing Colovac, a flexible endoluminal bypass sheath that minimizes fecal contact at the anastomotic site during colorectal surgery.
How much did they raise?
The company raised €35M in a Series C equity financing round led by Solar Eclipse, with participation from Gideon Strategic Partners, M&L Healthcare, and returning investor Sofinnova Partners.
What are their plans for the money?
With the new funds, SafeHeal plans to complete its IDE Pivotal study and accelerate the preparation for the commercial launch of Colovac, potentially transforming postoperative care for colorectal surgery patients.
What have they achieved so far?
SafeHeal has already advanced its lead technology to the clinical stage and is nearing a commercial launch, marking a significant milestone in offering patients an alternative to traditional ostomy procedures.
